| アブストラクト | We evaluated the applicability of a Clostridium difficile infection (CDI) risk index developed for patients at hospital discharge to identify persons at high-risk of CDI in a primary care population. This retrospective observational study used data from the UK Clinical Practice Research Datalink, linked with Hospital Episodes Statistics. The risk index was based on the following patient characteristics: age, previous hospitalizations, days in hospital, and prior antibiotics use. Individual risk scores were calculated by summing points assigned to pre-defined categories for each characteristic. We assessed the association of risk factors with CDI by multivariate logistic regression. The estimated CDI incidence rate was 4/10,000 and 2/10,000 person-years in 2008 and 2012, respectively. On an index with a maximal risk of 19, a cut-off for high risk of >/=7 had sensitivity, specificity and positive predictive values of 80%, 87% and 12%, respectively. A high-risk person had a ~ 35% higher risk of CDI than a low-risk person. Multivariate risk factor analysis indicated a need to reconsider the relative risk scores. The CDI risk index can be applied to the UK primary care population and help identify study populations for vaccine development studies. Reassessing the relative weights assigned to risk factors could improve the index performance in this setting. |
|---|
| ジャーナル名 | Human vaccines & immunotherapeutics |
|---|
| 投稿日 | 2019/4/5 |
|---|
| 投稿者 | Marley, Clare; El Hahi, Yassine; Ferreira, Germano; Woods, Laura; Ramirez Villaescusa, Ana |
|---|
| 組織名 | GSK , Brentford , UK.;Valesta c/o GSK , Mechelen , Belgium.;P95 , Heverlee , Belgium.;Department of Non communicable disease epidemiology, London School of Hygiene &;Tropical medicine , London , UK.;GSK , Wavre , Belgium. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/30945972/ |
|---|
